Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celia M Pombo

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinomaSusana B Bravo, María E R García-Rendueles, Rafael Seoane, et al.
Journal of Cellular and Molecular Medicine|July 10, 2026
Rapamycin Partially Reverts Cavernoma Endothelial Cell Phenotype and, When Combined With Lapatinib, Ameliorates Chronic LesionsMar García-Colomer, José E Martínez, Luis Díaz-Gómez, et al.
Molecular Medicine (Cambridge, Mass.)|May 7, 2026
Identification of the adhesion GPCR ADGRL4/ELTD1 as a novel potential prognostic biomarker for cerebral cavernous malformation diseaseAndrea Perrelli, Ashraqat Ahmed, Anna Onisiforou, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinomaSusana B Bravo, María E R García-Rendueles, Rafael Seoane, et al.
Journal of Cellular and Molecular Medicine|July 10, 2026
Rapamycin Partially Reverts Cavernoma Endothelial Cell Phenotype and, When Combined With Lapatinib, Ameliorates Chronic LesionsMar García-Colomer, José E Martínez, Luis Díaz-Gómez, et al.
Molecular Medicine (Cambridge, Mass.)|May 7, 2026
Identification of the adhesion GPCR ADGRL4/ELTD1 as a novel potential prognostic biomarker for cerebral cavernous malformation diseaseAndrea Perrelli, Ashraqat Ahmed, Anna Onisiforou, et al.
Pageof 2